drugset / Trial / NCT03536637

DMT310-001 Topical in the Treatment of Acne Vulgaris

NCT03536637

Phase 2 Completed 121 enrolled Dermata Therapeutics
RandomizedFactorialQuadruple-blindTreatment

Summary

The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne vulgaris.

Timeline

Start
2018-05-22
Primary completion
2018-12-30
Completion
2019-01-28

Drugs

EvaluationDrugModalityDoseRoute
Subject DMT310 Unknown Topical
Background Hydrogen Peroxide Small molecule

Indications